Skip to content

Clinical trials

Multiple Endocrine Neoplasia Type 1 trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Endocrine Neoplasia Type 1 Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20112
20152
20191
20201
20213
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Novartis Pharmaceuticals2
Amgen1
Centre Hospitalier Universitaire de Saint Etienne1
Centre Hospitalier Universitaire, Amiens1
Fondation Garches1
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement1
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques1
University Hospital, Bordeaux1
University Hospital, Clermont-Ferrand1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Endocrine Neoplasia Type 114
Breast Neoplasms2
Neoplasms2
Obesity2
Overweight2
Atherosclerosis1
Breast Diseases1
Coronary Disease1
Cystitis1
Discitis1

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.